Pathologists' examinations of tissue samples from skin cancer tumors improved when they were assisted by an AI tool. The ...

Trinity College Dublin now has Ireland's first and only BioBrillouin microscope, which will enable researchers to make giant ...

Minimal specimen requirements make it suitable for a wide range of tumor types and practice settings. The assay builds on the company’s tissue-based CGP platform, previously known as NeoComprehensive ...

This study introduces a valuable spring-bead model for epithelial cell layers, designed to improve previous cell-resolved approaches and to understand the connection between the biophysics of ...

As a commercial-stage company, Caris’s upsized public markets debut is an outlier amid the continuing IPO freeze for clinical ...

We utilized a tissue-free epigenomic assay for ctDNA detection (Guardant Reveal) with sampling prior to start of adjuvant therapy. Among ctDNA positives, epigenomic tumor fraction (TF) was estimated ...

PR Newswire FREMONT, Calif., May 15, 2025 First-of-its-kind panel includes brain-derived pTau217, pTau181, pTau231, and total tau assays to advance neurodegenerative disease research ...

Ultrasensitive ctDNA assay could detect post-surgery colorectal cancer recurrence well before imaging-based detection of clinical relapse, according to results presented by Emma Titmuss, MSc, at ...

Abstract. Context:Clinical trials are one of the major barriers in contemporary drug development. Functional assays based on patient-derived organoids (PDO) are a promising new tool for derisking ...

2.2 Commercial tissue-based indirect immunofluorescence assay and commercial cell-based assays All CSF samples were tested using the Euroimmun cIFA (FA 111a-1010-3, Euroimmun, Lübeck, Germany) on rat ...

Artificial intelligence (AI)-based histologic assays identify nonmuscle-invasive bladder cancer (NMIBC) cases at higher risks of recurrence, progression, nonresponse to intravesical bacillus ...